BRIEF published on 08/05/2024 at 15:50, 1 month 13 days ago Eckert & Ziegler étend la disponibilité de GalliaPharm® dans l'EEE Médecine Nucléaire GalliaPharm® Approbation EEE Générateurs De Radionucléides Diagnostics Rentables
PRESS RELEASE published on 08/05/2024 at 15:45, 1 month 13 days ago Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area Eckert & Ziegler SE extends availability of GalliaPharm® to the entire European Economic Area after receiving EC approval, offering cost-effective radiolabeling solution for PET diagnostics Eckert & Ziegler SE European Economic Area GalliaPharm® EC Approval Radiolabeling
BRIEF published on 07/16/2024 at 14:31, 2 months 2 days ago Eckert & Ziegler augmente ses ventes et ses bénéfices et relève ses prévisions de bénéfices pour 2024 Eckert & Ziegler EBIT Prévisions De Bénéfices La Croissance Des Ventes Résultats Financiers 2024
BRIEF published on 07/16/2024 at 14:31, 2 months 2 days ago Eckert & Ziegler Increases Sales and Earnings, Raises Profit Forecast for 2024 Sales Growth Eckert & Ziegler EBIT Profit Forecast 2024 Financial Results
PRESS RELEASE published on 07/16/2024 at 14:26, 2 months 2 days ago EQS-Adhoc: Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit Forecast Raised for 2024. Eckert & Ziegler SE reports impressive sales and earnings growth in the first half of 2024. Profit forecast raised for 2024 Sales Growth Earnings Increase Profit Forecast Eckert & Ziegler SE 2024 Financial Results
BRIEF published on 06/26/2024 at 16:32, 2 months 22 days ago Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG Annual General Meeting Dividend Eckert & Ziegler Pentixapharm AG Corporate Split-Off
BRIEF published on 06/26/2024 at 16:32, 2 months 22 days ago L'Assemblée générale annuelle d'Eckert & Ziegler SE approuve la scission de Pentixapharm AG Eckert & Ziegler Dividende Scission D'entreprise Assemblée Générale Annuelle Pentixapharm AG
PRESS RELEASE published on 06/26/2024 at 16:27, 2 months 22 days ago Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG The Annual General Meeting of Eckert & Ziegler SE has approved the split-off of Pentixapharm AG and declared a dividend of EUR 0.05 per share for 2023 Annual General Meeting Dividend Eckert & Ziegler SE Pentixapharm AG Split-off
BRIEF published on 06/25/2024 at 12:05, 2 months 23 days ago Eckert & Ziegler Subsidiary Pentixapharm Receives FDA Feedback to Initiate Phase III Trial with PentixaFor Pentixapharm FDA Phase III Trial Ga68-PentixaFor Primary Aldosteronism Radiopharmaceutical Diagnostic
BRIEF published on 06/25/2024 at 12:05, 2 months 23 days ago Pentixapharm, filiale d'Eckert & Ziegler, reçoit les commentaires de la FDA pour lancer un essai de phase III avec PentixaFor Pentixapharm Essai De Phase III De La FDA Ga68-PentixaPour Aldostéronisme Primaire Diagnostic Radiopharmaceutique
Published on 09/18/2024 at 23:10, 3 hours 50 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 4 hours ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 45 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 6 hours ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 10 hours 30 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 7 hours 48 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 8 hours 14 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 8 hours 28 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 46 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 9 hours 38 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 8 hours 14 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 8 hours 14 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 9 hours 20 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.